Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Löffler M, Weller M; for the German Glioma Network (2011)
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.
Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27385. [Epub ahead of print]
David Capper, Matthias Simon, Claus-Dieter Langhans, Jürgen G. Okun, Jörg C. Tonn, Michael Weller, Andreas von Deimling, Christian Hartmann, For the German Glioma Network (2011)
2-hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.
Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26425. [Epub ahead of print]
Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, Johannes Schramm, Oliver Schnell, Clemens Seidel, Robert Stein, Guido Reifenberger, Torsten Pietsch, Andreas von Deimling, Markus Loeffler, and Michael Weller; for the German Glioma Network (2011)
Molecular markers in low-grade gliomas: predictive or prognostic?
Clin Cancer Res. 2011 May 10. [Epub ahead of print]
Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Wilhelm Kreth F, Pietsch T, Loeffler M, Weller M, Reifenberger G, Tonn JC; for the German Glioma Network(2011)
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6, and PMS2 in paired primary and recurrent glioblastomas.
Int J Cancer. 2011 Mar 21.
O. Heese, M. Schmidt, S. Nickel, H. Berger, R. Goldbrunner, J.C. Tonn, O. Bähr, J.P. Steinbach, M. Simon, J. Schramm, D. Krex, G. Schackert, T. Reithmeier, G. Nikkhah, M. Löffler, M. Weller, M. Westphal, For the German Glioma Network (2010)
Complementary therapy use in patients with glioma: An observational study.
Neurology December 14, 2010 75:2229-2235
Christian Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch, Guido Reifenberger, Michael Weller, Markus Loeffler, Andreas von Deimling (2010)
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
Acta Neuropathol. 2010 Dec;120(6):707-18. Epub 2010 Nov 19.
Temme A, Geiger KD, Wiedemuth R, Conseur K, Pietsch T, Felsberg J, Reifenberger G, Tatsuka M, Hagel C, Westphal M, Berger H, Simon M, Weller M, Schackert G. (2010)
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
J Neuropathol Exp Neurol. 2010 Jun; 69(6):632-42.
Michael Weller, Jörg Felsberg, Christian Hartmann, Hilmar Berger, Joachim P. Steinbach, Johannes Schramm, Manfred Westphal, Gabriele Schackert, Matthias Simon, Jörg C. Tonn, Oliver Heese, Dietmar Krex, Guido Nikkhah, Torsten Pietsch, Otmar Wiestler, Guido Reifenberger, Andreas von Deimling, Markus Loeffler (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network.
J Clin Oncol. 2009 Oct 5. [Epub ahead of print].